Global Pharmaceuticals & Biotech Potentially Undervalued Companies

Viatris

Market Cap: US$12.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Genomma Lab Internacional. de

Market Cap: Mex$18.3b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Merck

Market Cap: €250.4b

Operates as a healthcare company worldwide.

Regeneron Pharmaceuticals

Market Cap: €74.2b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Merck KGaA

Market Cap: €52.5b

Operates as a science and technology company in Germany and internationally.

Daiichi Sankyo Company

Market Cap: €6.4t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Aspen Pharmacare Holdings

Market Cap: €42.1b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

Pelthos Therapeutics

Market Cap: US$80.7m

A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

Novartis

Market Cap: €205.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Evotec

Market Cap: US$962.2m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Iovance Biotherapeutics

Market Cap: US$873.3m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Sarepta Therapeutics

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

ACADIA Pharmaceuticals

Market Cap: US$4.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Novartis

Market Cap: CHF 205.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Tilray Brands

Market Cap: US$814.6m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

GSK

Market Cap: UK£72.4b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Bayer

Market Cap: €32.7b

Operates as a life science company worldwide.

Exelixis

Market Cap: US$11.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

CSL

Market Cap: €88.9b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Pharming Group

Market Cap: €966.1m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

GSK

Market Cap: €72.4b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

WuXi Biologics (Cayman)

Market Cap: US$134.3b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Telix Pharmaceuticals

Market Cap: US$5.0b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Novartis

Market Cap: CHF 205.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

GSK

Market Cap: €72.4b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Organon

Market Cap: US$1.9b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Biogen

Market Cap: US$26.7b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Fortrea Holdings

Market Cap: €1.3b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Sarepta Therapeutics

Market Cap: US$2.3b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Viatris

Market Cap: US$12.6b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

ACADIA Pharmaceuticals

Market Cap: US$2.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Beximco Pharmaceuticals

Market Cap: €53.1b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

hVIVO

Market Cap: €197.3m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Adaptimmune Therapeutics

Market Cap: €12.2m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Shanghai Junshi Biosciences

Market Cap: HK$36.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

China Traditional Chinese Medicine Holdings

Market Cap: HK$11.6b

China Traditional Chinese Medicine Holdings Co.